BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $95,000 | +39.7% | 1,500 | +91.6% | 0.01% | +60.0% |
| Q2 2021 | $68,000 | +23.6% | 783 | +30.5% | 0.01% | -16.7% |
| Q3 2020 | $55,000 | -30.4% | 600 | -41.5% | 0.01% | -40.0% |
| Q2 2020 | $79,000 | +426.7% | 1,025 | +282.5% | 0.01% | 0.0% |
| Q1 2020 | $15,000 | -79.2% | 268 | -70.2% | 0.01% | +42.9% |
| Q4 2019 | $72,000 | +100.0% | 900 | +80.0% | 0.01% | +75.0% |
| Q3 2019 | $36,000 | -52.0% | 500 | -37.5% | 0.00% | -50.0% |
| Q2 2019 | $75,000 | +29.3% | 800 | +7.0% | 0.01% | +100.0% |
| Q3 2018 | $58,000 | +93.3% | 748 | +124.0% | 0.00% | +33.3% |
| Q1 2018 | $30,000 | -79.5% | 334 | -82.8% | 0.00% | -78.6% |
| Q4 2017 | $146,000 | +4766.7% | 1,944 | +3500.0% | 0.01% | – |
| Q3 2017 | $3,000 | -89.7% | 54 | -90.7% | 0.00% | -100.0% |
| Q2 2017 | $29,000 | -70.7% | 583 | -76.5% | 0.00% | -70.0% |
| Q1 2017 | $99,000 | -8.3% | 2,482 | -35.6% | 0.01% | -16.7% |
| Q4 2016 | $108,000 | – | 3,854 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |